The Stereotactic Radiosurgery Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Indication (Head & Neck Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Spine Cancer, Others), By End-User (Hospitals, Radiotherapy Centers, Others).
In 2024, the market for stereotactic radiosurgery (SRS) continues to be at the forefront of non-invasive treatment modalities for intracranial and extracranial tumors, vascular malformations, and functional disorders of the brain and spine. Stereotactic radiosurgery delivers precisely targeted radiation to pathological tissue while sparing surrounding healthy tissue, utilizing advanced imaging, computerized planning, and radiation delivery systems. With advancements in linear accelerator technology, robotic platforms, and image guidance, stereotactic radiosurgery offers improved accuracy, safety, and treatment outcomes compared to conventional radiation therapy techniques. Moreover, the market is influenced by trends such as the expansion of indications for SRS to include oligometastatic disease, recurrent tumors, and benign intracranial lesions, as well as the integration of hypofractionated regimens and immunotherapy approaches for enhanced tumor control and survival outcomes. Additionally, ongoing research focuses on optimizing treatment protocols, refining dosimetry techniques, and investigating novel radiation sensitizers and radioprotectors to further improve the efficacy and safety of stereotactic radiosurgery across a wide range of clinical applications, reflecting the continuous innovation and advancement in radiation oncology practices and technologies.
A significant trend in the stereotactic radiosurgery market is the increasing adoption for the non-invasive treatment of various brain disorders. Stereotactic radiosurgery, utilizing precise radiation beams to target specific areas in the brain, offers a minimally invasive alternative to traditional surgical procedures for conditions such as brain tumors, arteriovenous malformations (AVMs), trigeminal neuralgia, and other neurological disorders. This trend is driven by advancements in technology, including image-guided radiation therapy (IGRT) and robotic stereotactic systems, which enable highly accurate and targeted delivery of radiation while minimizing damage to surrounding healthy tissues. As patients and healthcare providers seek safer and more effective treatment options for brain disorders, stereotactic radiosurgery has emerged as a preferred choice, leading to increased adoption and market growth.
A primary driver propelling the stereotactic radiosurgery market forward is the rising incidence of brain tumors and neurological disorders worldwide. Brain tumors, including both malignant and benign tumors, represent a significant healthcare burden, with increasing diagnosis rates attributed to factors such as aging populations, improved diagnostic techniques, and environmental factors. Additionally, neurological disorders such as AVMs, trigeminal neuralgia, and movement disorders are also on the rise, contributing to the demand for effective treatment modalities. Stereotactic radiosurgery offers a valuable therapeutic option for these conditions, providing precise and targeted radiation therapy with minimal risk of complications compared to traditional surgery. The growing incidence of brain tumors and neurological disorders, coupled with advancements in radiosurgical technology and techniques, drives the demand for stereotactic radiosurgery and supports market growth.
An opportunity within the stereotactic radiosurgery market lies in the expansion into multidisciplinary treatment centers that offer comprehensive care for patients with complex brain disorders. While stereotactic radiosurgery is primarily performed by radiation oncologists and neurosurgeons, there is increasing recognition of the benefits of a multidisciplinary approach to patient care, involving collaboration among various specialists such as neurologists, neuroradiologists, medical physicists, and radiation therapists. Multidisciplinary treatment centers provide patients with access to a range of expertise and resources, allowing for personalized treatment plans tailored to individual needs and preferences. By expanding into multidisciplinary treatment centers, stereotactic radiosurgery providers can offer integrated and holistic care for patients with brain tumors and neurological disorders, improve treatment outcomes, and differentiate themselves in the competitive healthcare landscape. Additionally, partnerships with hospitals, academic institutions, and healthcare networks can facilitate the establishment of multidisciplinary treatment centers and enhance patient access to stereotactic radiosurgery services, driving market expansion and revenue growth.
In the Stereotactic Radiosurgery (Gamma Knife) Market, the indication segment of Head & Neck Cancer is experiencing rapid growth. Stereotactic radiosurgery, including Gamma Knife radiosurgery, offers a precise and effective treatment option for head and neck cancers, including tumors of the brain, skull base, and upper cervical spine. The non-invasive nature of Gamma Knife radiosurgery, coupled with its ability to deliver high doses of radiation to targeted tumors while minimizing radiation exposure to surrounding healthy tissues, makes it an attractive treatment modality for patients with head and neck cancers. As the incidence of head and neck cancers continues to rise globally, driven by factors such as tobacco and alcohol consumption, human papillomavirus (HPV) infection, and aging populations, there is a growing demand for advanced and less invasive treatment options. Hospitals, radiotherapy centers, and other healthcare facilities are the primary end-users offering Gamma Knife radiosurgery for head and neck cancer treatment, reflecting its widespread adoption in clinical practice. With ongoing technological advancements in Gamma Knife technology, such as improved treatment planning software and image-guided navigation systems, the market for Gamma Knife radiosurgery in head and neck cancer treatment is poised for continued rapid growth.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAccuray Inc, Elekta AB, Elsan, Qfix, Varian Medical Systems Inc, Vision RT Ltd
By Indication
Head & Neck Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Spine Cancer
Others
By End-User
Hospitals
Radiotherapy Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Accuray Inc
Elekta AB
Elsan
Qfix
Varian Medical Systems Inc
Vision RT Ltd
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Stereotactic Radiosurgery Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Stereotactic Radiosurgery Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Stereotactic Radiosurgery Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Stereotactic Radiosurgery Market Size Outlook, $ Million, 2021 to 2030
3.2 Stereotactic Radiosurgery Market Outlook by Type, $ Million, 2021 to 2030
3.3 Stereotactic Radiosurgery Market Outlook by Product, $ Million, 2021 to 2030
3.4 Stereotactic Radiosurgery Market Outlook by Application, $ Million, 2021 to 2030
3.5 Stereotactic Radiosurgery Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Stereotactic Radiosurgery Industry
4.2 Key Market Trends in Stereotactic Radiosurgery Industry
4.3 Potential Opportunities in Stereotactic Radiosurgery Industry
4.4 Key Challenges in Stereotactic Radiosurgery Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Stereotactic Radiosurgery Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Stereotactic Radiosurgery Market Outlook by Segments
7.1 Stereotactic Radiosurgery Market Outlook by Segments, $ Million, 2021- 2030
By Indication
Head & Neck Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Spine Cancer
Others
By End-User
Hospitals
Radiotherapy Centers
Others
8 North America Stereotactic Radiosurgery Market Analysis and Outlook To 2030
8.1 Introduction to North America Stereotactic Radiosurgery Markets in 2024
8.2 North America Stereotactic Radiosurgery Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Stereotactic Radiosurgery Market size Outlook by Segments, 2021-2030
By Indication
Head & Neck Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Spine Cancer
Others
By End-User
Hospitals
Radiotherapy Centers
Others
9 Europe Stereotactic Radiosurgery Market Analysis and Outlook To 2030
9.1 Introduction to Europe Stereotactic Radiosurgery Markets in 2024
9.2 Europe Stereotactic Radiosurgery Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Stereotactic Radiosurgery Market Size Outlook by Segments, 2021-2030
By Indication
Head & Neck Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Spine Cancer
Others
By End-User
Hospitals
Radiotherapy Centers
Others
10 Asia Pacific Stereotactic Radiosurgery Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Stereotactic Radiosurgery Markets in 2024
10.2 Asia Pacific Stereotactic Radiosurgery Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Stereotactic Radiosurgery Market size Outlook by Segments, 2021-2030
By Indication
Head & Neck Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Spine Cancer
Others
By End-User
Hospitals
Radiotherapy Centers
Others
11 South America Stereotactic Radiosurgery Market Analysis and Outlook To 2030
11.1 Introduction to South America Stereotactic Radiosurgery Markets in 2024
11.2 South America Stereotactic Radiosurgery Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Stereotactic Radiosurgery Market size Outlook by Segments, 2021-2030
By Indication
Head & Neck Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Spine Cancer
Others
By End-User
Hospitals
Radiotherapy Centers
Others
12 Middle East and Africa Stereotactic Radiosurgery Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Stereotactic Radiosurgery Markets in 2024
12.2 Middle East and Africa Stereotactic Radiosurgery Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Stereotactic Radiosurgery Market size Outlook by Segments, 2021-2030
By Indication
Head & Neck Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Spine Cancer
Others
By End-User
Hospitals
Radiotherapy Centers
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Accuray Inc
Elekta AB
Elsan
Qfix
Varian Medical Systems Inc
Vision RT Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Indication
Head & Neck Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Spine Cancer
Others
By End-User
Hospitals
Radiotherapy Centers
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Stereotactic Radiosurgery Market is one of the lucrative growth markets, poised to register a 5.9% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Accuray Inc, Elekta AB, Elsan, Qfix, Varian Medical Systems Inc, Vision RT Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume